Active Substance & Generic Molecule Directory

Adalimumab in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Adalimumab registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

10
Registered Brands
Availability in Malaysia:10 Prescription (MAL-A)
Showing 10 of 10 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL19056100AZAMGEVITA 20 mg/0.4 ml solution for injection in pre-filled syringe20mg/0.4mlPrescription (MAL-A)Amgen Biopharmaceuticals Malaysia Sdn BhdCompare →
MAL25076012AZAMGEVITA 40 mg/0.4 ml solution for injection in pre-filled autoinjector40 mgPrescription (MAL-A)Amgen Biopharmaceuticals Malaysia Sdn BhdCompare →
MAL19056105AZAMGEVITA 40 mg/0.8 ml solution for injection in pre-filled autoinjector40 mgPrescription (MAL-A)Amgen Biopharmaceuticals Malaysia Sdn BhdCompare →
MAL19056101AZAMGEVITA 40 mg/0.8 ml solution for injection in pre-filled syringe40 mg/ 0.8 mlPrescription (MAL-A)Amgen Biopharmaceuticals Malaysia Sdn BhdCompare →
MAL17107006ACRZHumira Solution for Injection in Pre-filled Pen 40mg/0.4ml40mgPrescription (MAL-A)ABBVIE SDN BHDCompare →
MAL17107005ACRZHumira Solution for Injection in Pre-filled Syringe 40mg/0.4ml40mgPrescription (MAL-A)ABBVIE SDN BHDCompare →
MAL25096008ACZHyrimoz 40mg/0.4ml Solution for Injection in Pre-Filled Pen40 mgPrescription (MAL-A)SANDOZ PRODUCTS MALAYSIA SDN. BHD.Compare →
MAL22016007ACZHyrimoz 40mg/0.8ml Solution for Injection in Pre-Filled Pen40 mgPrescription (MAL-A)SANDOZ PRODUCTS MALAYSIA SDN. BHD.Compare →
MAL24056003AZYuflyma 10mg/0.1ml Solution for Injection in pre-filled pen10 mg 0.1 mlPrescription (MAL-A)CELLTRION HEALTHCARE MALAYSIA SDN. BHD.Compare →
MAL26096007AZYuflyma 20mg/0.2mL solution for injection in pre-filled syringe20 mg 0.2 mlPrescription (MAL-A)CELLTRION HEALTHCARE MALAYSIA SDN. BHD.Compare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.